Incidence of end stage renal disease among type 1 diabetes: A nationwide cohort study in Taiwan

Medicine (United States)

Volumn 93, Issue 28, 2014, Pages e274-

  Lin, Wei Hung ^a,b   Li, Chung Yi ^a,c   Wang, Wei Ming ^b   Yang, Deng Chi ^a,b   Kuo, Te Hui ^a,b   Wang, Ming Cheng ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; COHORT ANALYSIS; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; DISEASE REGISTRY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; POPULATION RESEARCH; REGISTRATION; RISK ASSESSMENT; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; TAIWANESE; AGE DISTRIBUTION; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 1; KIDNEY FAILURE, CHRONIC; MULTICENTER STUDY; RETROSPECTIVE STUDY; SEX RATIO; TAIWAN; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84920190205     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000274     Document Type: Article

References (31)

1. Asao K, Sarti C, Forsen T, et al. Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care. 2003; 26: 2037-2042.
2. Nishimura R, LaPorte RE, Dorman JS, et al. Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999. Diabetes care. 2001; 24: 823-827.
3. Shankar A, Klein R, Klein BE, Moss SE. Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. Am J Epidemiol. 2007; 166: 393-402.
4. Krolewski AS, Warram JH, Christlieb AR, et al. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985; 78: 785-794.
5. Cowie CC, Port FK, Wolfe RA, et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989; 321: 1074-1079.
6. Stephens GW, Gillaspy JA, Clyne D, et al. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. Am J Kidney Dis. 1990; 15: 562-567.
7. Lin WH, Wang MC, Wang WM, et al. Incidence of and mortality from type i diabetes in Taiwan from 1999 through 2010: a nationwide cohort study. PLoS ONE. 2014; 9: e86172.
8. Patterson CC, Gyurus E, Rosenbauer J, et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia. 2012; 55: 2142-2147.
9. U.S. Renal Data System (2012) Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
10. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008; 371: 2173-2182.
11. Matsushima M, Tajima N, LaPorte RE, et al. Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Diabetologia. 1995; 38: 236-243.
12. Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 1996; 50: 2041-2046.
13. Xue JL, Eggers PW, Agodoa LY, et al. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol. 2007; 18: 1299-1306.
14. Sun Y, Chang YH, Chen HF, et al. Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care. 2012; 35: 1047-1049.
15. Lin WH, Guo CY, Wang WM, et al. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan. Int J Rheum Dis. 2013; 16: 747-753.
16. Lawrence JM, Black MH, Zhang JL, et al. Validation of pediatric diabetes case identification approaches for diagnosed cases by using information in the electronic health records of a large integrated managed health care organization. Am J Epidemiol. 2014; 179: 27-38.
17. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc. 1999; 94: 496-509.
18. Finnish Registry for Kidney Diseases. Report 2012. Helsinki, Finland: Finnish Registry for Kidney Diseases; 2012. Available at: http://www.musili.fi/smtr/english.
19. Finne P, Reunanen A, Stenman S, et al. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA. 2005; 294: 1782-1787.
20. Chen YR, Yang Y, Wang SC, et al. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study. Nephrol Dial Transplant. 2013; 28: 671-682.
21. Rosolowsky ET, Skupien J, Smiles AM, et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol. 2011; 22: 545-553.
22. Costacou T, Fried L, Ellis D, Orchard TJ. Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis. Am J Kidney Dis. 2011; 58: 565-573.
23. Peralta CA, Shlipak MG, Fan D, et al. Risks for end-stage renal disease, cardiovascular events and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006; 17: 2892-2899.
24. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003; 14: 2902-2907.
25. Brancati FL, Whittle JC, Whelton PK, et al. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA. 1992; 268: 3079-3084.
26. Hall YN, Hsu CY, Iribarren C, et al. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int. 2005; 68: 2310-2316.
27. Barbour SJ, Er L, Djurdjev O, et al. Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients. Nephrol Dial Transplant. 2010; 25: 3663-3672.
28. Karter AJ, Ferrara A, Liu JY, et al. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002; 287: 2519-2527.
29. Chandie Shaw PK, Baboe F, van Es LA, et al. South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care. 2006; 29: 1383-1385.
30. Forsblom C, Harjutsalo V, Thorn LM, et al. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol. 2011; 22: 537-544.
31. Lecaire TJ, Klein BE, Howard KP, et al. Risk for end-stage renal disease over 25 years in the population-based WESDR cohort. Diabetes Care. 2014; 37: 381-388.